This one-hour, on-demand, journal article-based activity reviews a large cross-sectional study of kratom consumers to evaluate the potential risk for dependency and addiction with kratom consumption and assess the prevalence of kratom use disorder. Up to this time, research about kratom use bas been limited and the prevalence of Kratom Use Disorder (KUD) and indivudual characteristics associated with KUD has not been well understood. The purpose of this study is to improve to gain a clearer clinical understanding of Kratom Use Disorder and better inform the medical community that interacts with patients who consume kratom about the risks of KUD development.

This one-hour, on-demand, journal article-based activity explores original qualitative research on patient perspectives regarding buprenorphine​ discontinuation in the treatment of opioid use disorder (OUD). Little is currently known about the causes of medication discontinuation from the patient perspective. ​Despite buprenorphine and other medications for OUD being the recommended standard care of treatment for OUD and the benefits of positive health and addiction-related outcomes associated with them​, half of patients discontinue medication use in the first year of treatment. Emerging in interviews with patients with OUD treated with buprenorphine were three main themes related to medication discontinuation: health system barriers, adverse effects (or apparent adverse events) associated with the medication, and patient motivations. The purpose of this activity is to better understand patient perspectives around themes of discontinuation and to explore some clinical strategies to enhance patient retention.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses harm reduction strategies such as needle/syringe exchange programs, naloxone opioid overdose rescue kits, bridge clinics, and low-barrier medication for opioid use disorder.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses existing housing models for people with substance use disorders, the evidence base behind these models, and funding mechanisms for each model.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the importance of discussing surrogate decision makers in patients with use disorders.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses optimized pharmacotherapy, counsel effectively and offer tobacco cessation resources to all patients who use tobacco.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the fundamentals of PrEP and the unique challenges of PrEP among PWIDs.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the recent and historical trends in adulterants and contaminants including sulfonylureas, levamisole, local anesthetics, quinine, stimulants, opioids, brodifacoum, and alpha 2 agonists in the illicit drug supply.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses POCUS as an important modality in addiction medicine practice by reviewing POCUS' benefits, fundamentals/definitions, and data supporting its use.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the implementation of a rural county jail harm reduction program with an addiction medicine physician, jail commander, and peer support specialist.